Clinical Treatment of Patients with Diabetes and Cardiometabolic Disease – A Conversation With an Endocrinologist, Cardiologists and a Nephrologist

Chairs: Ofri Mosenzon (ISR), Rich Pratley (USA)
Faculty: Chris Cannon (USA), David Cherney (CAN)

18:30 – 18:33Opening RemarksChairs (ISR, USA)
18:33 – 18:41Highlighting the Patient with Diabetes and Cardiometabolic DiseaseRich Pratley (USA)
18:41 – 18:49Answering Unmet Needs – Clinical Understanding of Recent Heart Failure Data for Patients with Diabetes and Cardiovascular DiseaseChris Cannon (USA)
18:49 – 18:57Adding to the Clinical Understanding for Patients with Diabetes and Cardio-renal DiseaseDavid Cherney (CAN)
18:57 – 19:27 A Cross-Specialty Faculty Roundtable on Meeting the Needs of Patients with Diabetes and Established Cardiometabolic Disease: Are SGLT2is Best Utilized as a Cardiovascular Drug? A Kidney Drug? A Glycemic Lowering Agent? Or All of the Above?Faculty
19:27 – 19:30Closing RemarksChairs (ISR, USA)